What Sophrosyne Technologies does

Sophrosyne Technologies is a Bengaluru-headquartered, fabless semiconductor startup developing a multi-vital biosensing System-on-Chip (SoC) for original equipment manufacturers of wearable and digital health devices. The company's flagship chip integrates four physiological sensing modalities — electrocardiography (ECG), photoplethysmography (PPG), respiration, and temperature — onto a single ultra-low-power die, augmented by proprietary on-chip AI models for biosignal processing and interpretation. The architecture is positioned for both consumer-grade wearables (smartwatches, fitness trackers) and clinical-grade medical monitoring devices, with design emphasis on compact form factor, low energy consumption, and high-precision signal fidelity required for medical applications.

The company operates a horizontal go-to-market selling chipsets directly to OEMs for integration into their end products, rather than producing finished devices or consumer apps. As of the latest available data, Sophrosyne has no named commercial customers and is transitioning from prototype silicon to full-scale production. The firm raised a $2 million seed round led by Bluehill.VC in November 2025 and secured a $1.2 million Design Linked Incentive grant from India's Ministry of Electronics and Information Technology (MeitY) under the same period, providing combined funding of approximately $3.2 million to fund the production transition and engineering expansion.

Sophrosyne operates from a Bengaluru headquarters, an expanded R&D and product design centre in Udupi, Karnataka (inaugurated December 2025), and is incubated at the Centre for Medical Innovation at the Government Institute of Medical Sciences in Greater Noida — a hospital-based innovation ecosystem supporting over 40 active startups with clinical validation infrastructure. Headcount scaled from 6 to 30 employees over approximately one year, with stated plans to grow beyond 50 within 18 months. Revenue is not disclosed and the company is classified as pre-revenue based on available signals.

Name

Sophrosyne Technologies

Legal name

Sophrosyne Technologies

Website

https://sophrosynetechnologies.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Sophrosyne Technologies is a Bengaluru-based fabless semiconductor startup developing a multi-vital biosensing System-on-Chip integrating ECG, PPG, respiration, and temperature with proprietary on-chip AI, sold to wearable and digital health device OEMs globally.

Ownership category

akta.pro rank

Product category

Medical-grade Semiconductor Chipsets

NAICS

Semiconductor and Related Device Manufacturing (334413), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

System-on-Chip (SoC) Platforms (Mobile/Consumer/Embedded) (HDAHAJAC)

akta.pro secondary industries

Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK), Sensor Fusion, Interface ICs & Modules (AFE/Readout/Packaging/Calibration) (HDAHALAO), Wearables & Consumer IoT Integration Platforms (BYOD) (HLACAFAF), Continuous Temperature & Fever Monitoring (Wearable Thermometry) (HLAHACAK)

Keywords

• Biosensing semiconductor chipsets
• Wearable health monitoring
• System on chip design
• Medical grade semiconductors
• Fabless semiconductor company

Headquarters

HQ city

Udupi

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Semiconductor Chipsets Sales: Sale of medical-grade semiconductor chipsets (SoC) to wearable and health device manufacturers. The company operates as a fabless semiconductor startup, likely selling chips directly to OEM customers for integration into end products.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

Sophrosyne Technologies designs and sells a multi-vital biosensing System-on-Chip (SoC) for wearable and digital health devices. The single chip integrates ECG, PPG, respiration rate, and temperature monitoring with proprietary AI models for signal processing, targeting OEMs of consumer wearables and clinical-grade health devices. The company operates as a fabless semiconductor startup.

Product overview

Sophrosyne Technologies operates as a fabless semiconductor startup developing a unified multi-vital biosensing System-on-Chip platform. The core product integrates ECG, PPG, respiration, and temperature monitoring capabilities into a single ultra-low-power chip with proprietary AI models for signal processing, designed for wearable and clinical health device applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Multi-Vital Biosensing SoC

Quantifiable outcome

• Multi-vital health monitoring (ECG, PPG, respiration, temperature) integrated in single ultra-low-power chip

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

One partnership is on record.

• Centre for Medical Innovation (CMI) at Government Institute of Medical SciencescoreStrategic or Co-development Partner · 30 January 2026Sophrosyne is incubated at CMI in Greater Noida, operating within a hospital-based innovation ecosystem that supports over 40 active startups, providing access to medical expertise and clinical validation environment.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Maxim Integrated: Now part of Analog Devices, Maxim was historically a leading supplier of biosensor ICs and health-wearable analog front-ends (e.g., MAX-HEALTH series). Comparable to Sophrosyne's multi-vital biosensing SoC strategy and directly relevant as the de facto incumbent in vital-sign sensing silicon.
• Analog Devices: Analog Devices (including Maxim Integrated) is a leading supplier of vital-sign monitoring analog front-ends and biosensor ICs for ECG, PPG, and wearable health applications. It is the most directly comparable competitor to Sophrosyne's multi-vital biosensing SoC, with established OEM design wins and clinical-grade positioning.
• ams OSRAM: Specialist in optical sensing, including PPG and biosensor solutions for wearables and hearables, with a deep portfolio of integrated multi-vital health monitoring modules. Directly comparable to Sophrosyne's biosensing SoC strategy of combining multiple vital-sign sensing modalities on a single chip.

Broad incumbents

• Renesas Electronics: Japanese semiconductor company with low-power MCU and analog front-end solutions for healthcare and wearable applications, including vital-sign monitoring reference designs. Comparable to Sophrosyne as a competing silicon vendor for medical and wearable OEMs.
• Infineon Technologies: German semiconductor major with a portfolio spanning power, sensing, and connectivity for health and wearable applications. Comparable to Sophrosyne as a competitor targeting similar OEM customers in wearables and digital health, but with a substantially broader product line and global footprint.
• STMicroelectronics: Major European semiconductor vendor producing low-power MCUs, MEMS sensors, and health/wearable SoCs used across consumer and medical wearables. Comparable to Sophrosyne as a silicon supplier targeting the same wearable health OEM customers, though with a much broader portfolio.
• MediaTek: Major Asian fabless semiconductor company producing low-power SoCs for wearables, hearables, and IoT health devices. Comparable to Sophrosyne as a fabless competitor serving similar Asian OEM customers in the consumer wearable category.
• Qualcomm: Designs the Snapdragon Wear platforms that power a large share of premium smartwatches and wearables, with integrated sensor hubs and health signal processing. Comparable to Sophrosyne as a competing silicon supplier to wearable OEMs, though at application-processor scale rather than dedicated biosensing SoCs.
• Texas Instruments: Global analog and embedded semiconductor leader with a broad portfolio of low-power SoCs and analog front-ends used in wearable and medical devices. Comparable to Sophrosyne as a competing supplier of biosensing and embedded processing silicon for health wearables, but at vastly greater scale and product breadth.

Emerging players

• Silicon Labs: Fabless vendor focused on low-power wireless SoCs and sensor processing for IoT and wearable endpoints. Comparable to Sophrosyne in the low-power SoC and embedded AI domains serving connected health devices, though with a stronger wireless/protocol emphasis than biosensing.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sophrosyne-technologies

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sophrosyne Technologies